← All organizations
Highest phase reached
Phase 3
First clinical trial
Sep 1, 2001First marketed drug
Jul 27, 2004First NDA
Jul 27, 2004Last known activity
Jan 4, 2025
Timeline
1990s
- Jun 1, 1997
Photocure— Founded
2000s
- Jul 27, 2004
methyl aminolevulinate— NDA Organization
2010s
- May 28, 2010
hexyl 5-aminolevulinate— NDA Secondary Org
Drugs by trial phase (5 distinct, 20 trials)
Phase 3 (2 own, 0 via acquisition)
Phase 2 (3 own, 0 via acquisition)
Indications
Approved for
Marketed drugs (2)
Recent trials (21)
- NCT06525571CollaboratorPhase 3Jan 4, 2025
- NCT05600322Lead sponsorPhase 3Oct 31, 2022
- NCT02560584Lead sponsorPhase 3Oct 1, 2015
- NCT01551407Lead sponsorPhase 2Dec 1, 2011
- NCT01282515CollaboratorPhase 2/Phase 3Aug 1, 2011
- NCT01347879Lead sponsorPhase 2May 1, 2011
- NCT01256424Lead sponsorPhase 2Apr 1, 2011
- NCT01160848Lead sponsorPhase 2Aug 1, 2010
- NCT01050309Study directorPhase 1Nov 1, 2009
- NCT01050309Lead sponsorPhase 1Nov 1, 2009
- NCT00933543Lead sponsorPhase 2Aug 1, 2009
- NCT01344902Lead sponsorPhase 1/Phase 2Feb 1, 2009
- NCT00708942Lead sponsorPhase 2Jan 1, 2009
- NCT00673933Lead sponsorPhase 2May 1, 2008
- NCT00833183Lead sponsorPhase 2Jul 1, 2007
Details
- Founded
- Oslo, NO Jun 1, 1997
- First NDA
- Jul 27, 2004
- Last known activity
- Jan 4, 2025